María Lagarde

971 total citations
23 papers, 200 citations indexed

About

María Lagarde is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, María Lagarde has authored 23 papers receiving a total of 200 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 9 papers in Virology and 8 papers in Epidemiology. Recurrent topics in María Lagarde's work include HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (7 papers) and HIV/AIDS Research and Interventions (6 papers). María Lagarde is often cited by papers focused on HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (7 papers) and HIV/AIDS Research and Interventions (6 papers). María Lagarde collaborates with scholars based in Spain, France and United States. María Lagarde's co-authors include Otilia Bisbal, Federico Pulido, José Ramón Arribas, Mariano Matarranz, Asunción Hernando, Rafael Rubio, Carmen Bayón, Sergio Serrano‐Villar, José Ramón Blanco and Francisco Arnalich and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

María Lagarde

20 papers receiving 198 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
María Lagarde Spain 8 131 94 52 47 42 23 200
Margherita Digaetano Italy 9 131 1.0× 99 1.1× 64 1.2× 31 0.7× 41 1.0× 19 253
Guglielmo Marco Migliorino Italy 10 106 0.8× 56 0.6× 50 1.0× 15 0.3× 34 0.8× 20 201
J. Timpone United States 4 118 0.9× 127 1.4× 60 1.2× 25 0.5× 23 0.5× 5 204
Chiara Montrucchio Italy 9 126 1.0× 63 0.7× 83 1.6× 23 0.5× 41 1.0× 14 211
Alessia Zoncada Italy 8 115 0.9× 56 0.6× 52 1.0× 18 0.4× 10 0.2× 13 169
Andrés Esteban-Cantos Spain 10 88 0.7× 100 1.1× 88 1.7× 53 1.1× 92 2.2× 14 253
Carlos Azuaje Spain 8 177 1.4× 79 0.8× 58 1.1× 10 0.2× 46 1.1× 9 200
Bryan T. Mogle United States 5 129 1.0× 42 0.4× 47 0.9× 31 0.7× 7 0.2× 9 219
Anjana Grandhi United States 8 246 1.9× 51 0.5× 149 2.9× 19 0.4× 15 0.4× 14 287
Georgios Adamis Greece 7 35 0.3× 23 0.2× 76 1.5× 18 0.4× 19 0.5× 16 139

Countries citing papers authored by María Lagarde

Since Specialization
Citations

This map shows the geographic impact of María Lagarde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by María Lagarde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites María Lagarde more than expected).

Fields of papers citing papers by María Lagarde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by María Lagarde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by María Lagarde. The network helps show where María Lagarde may publish in the future.

Co-authorship network of co-authors of María Lagarde

This figure shows the co-authorship network connecting the top 25 collaborators of María Lagarde. A scholar is included among the top collaborators of María Lagarde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with María Lagarde. María Lagarde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Vivancos, María Jesús, María Lagarde, Eva Orviz, et al.. (2024). Transition times across the HIV care continuum in Spain from 2005 to 2022: a longitudinal cohort study. The Lancet HIV. 11(7). e470–e478. 1 indexed citations
3.
Buckley, Rosa de Miguel, Rocío Montejano, María Jiménez-González, et al.. (2022). Long-term Evaluation of Residual Viremia in a Clinical Trial of Dolutegravir Plus Lamivudine as Maintenance Treatment for Participants With and Without Prior Lamivudine Resistance. Open Forum Infectious Diseases. 9(11). ofac610–ofac610. 7 indexed citations
4.
Bisbal, Otilia, et al.. (2021). Incidence and Severity of SARS-CoV-2 Infection in HIV-Infected Individuals During the First Year of the Pandemic. JAIDS Journal of Acquired Immune Deficiency Syndromes. 89(5). 511–518. 8 indexed citations
5.
Domínguez, Lourdes, Otilia Bisbal, Mariano Matarranz, et al.. (2019). Predictive factors of hepatitis C virus eradication after interferon-free therapy in HIV coinfection. European Journal of Clinical Microbiology & Infectious Diseases. 38(4). 725–734. 6 indexed citations
6.
Domínguez, Lourdes, Mariano Matarranz, María Lagarde, et al.. (2019). HCV eradication with all-oral therapy in cirrhotic HIV-coinfected patients: an observational study of early changes in liver function and fibrosis tests. Revista Española de Enfermedades Digestivas. 111(8). 626–632.
7.
Domínguez, Lourdes, María Lagarde, Otilia Bisbal, et al.. (2019). Sustained virological response at week 12 after interferon-free therapy as criterion for HCV cure definition: Validation in a real-life cohort of HIV-coinfected patients. Enfermedades Infecciosas y Microbiología Clínica. 38(6). 275–278. 3 indexed citations
8.
Serrano‐Villar, Sergio, María Lagarde, Jorge F. Vázquez‐Castellanos, et al.. (2018). Effects of Immunonutrition in Advanced Human Immunodeficiency Virus Disease: A Randomized Placebo-controlled Clinical Trial (Promaltia Study). Clinical Infectious Diseases. 68(1). 120–130. 40 indexed citations
9.
Bayón, Carmen, Asunción Hernando, Félix Gutiérrez, et al.. (2016). Toward a comprehensive care of HIV patients: finding a strategy to detect depression in a Spanish HIV cohort. AIDS Care. 28(7). 834–841. 3 indexed citations
10.
Rubio, Rafael, Mariano Matarranz, Otilia Bisbal, María Lagarde, & Lourdes Domínguez. (2016). Efectividad y seguridad de darunavir a largo plazo. Enfermedades Infecciosas y Microbiología Clínica. 34. 16–22. 1 indexed citations
11.
Pillet, Pascal, et al.. (2015). Syndrome d'activation macrophagique: diagnostic et prise en charge aux urgences. Archives de Pédiatrie. 22(5). 143–144. 1 indexed citations
12.
Richer, Olivier, et al.. (2015). Douleur abdominale aiguë: quand penser à une maladie rare?. Archives de Pédiatrie. 22(5). 145–146. 1 indexed citations
13.
Valero, Ignacio, Miriam Estébanez, Susana Monge, et al.. (2014). A Prospective Cohort Study of Neurocognitive Function in Aviremic HIV-Infected Patients Treated With 1 or 3 Antiretrovirals. Clinical Infectious Diseases. 59(11). 1627–1634. 17 indexed citations
14.
Bisbal, Otilia, Agustı́n Gómez de la Cámara, Asunción Hernando, et al.. (2014). Presentadores tardíos de la infección por el vih: prevalencia, características epidemiológicas, factores de riesgo, manifestaciones clínicas y supervivencia.
15.
Carvajal, Fernando, Carmen Bayón, Ignacio Valero, et al.. (2014). Pattern of neurocognitive function in patients receiving boosted protease inhibitor monotherapy: a detailed neuropsychological study. Journal of NeuroVirology. 20(4). 362–370. 7 indexed citations
16.
Valero, Ignacio, Miriam Estébanez, Carmen Bayón, et al.. (2013). Neurocognitive Impairment in Patients Treated with Protease Inhibitor Monotherapy or Triple Drug Antiretroviral Therapy. PLoS ONE. 8(7). e69493–e69493. 18 indexed citations
17.
Gasch, Oriol, Mariana Camoez, M.Á. Domínguez, et al.. (2013). Predictive factors for early mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia. Journal of Antimicrobial Chemotherapy. 68(6). 1423–1430. 35 indexed citations
18.
Estébanez, Miriam, Marisa Montes, Carmen Bayón, et al.. (2012). Prolonged treatment with boosted protease inhibitor monotherapy is not associated with a higher rate of neurocognitive impairment than triple drug ART. Journal of the International AIDS Society. 15(S4). 1–2. 2 indexed citations
19.
20.
Hernández, P, et al.. (1972). [Use of intravenous urea in the treatment of the patinful crises of sickle cell anemia].. PubMed. 24(1). 83–9. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margherita Digaetano Breakdown of academic impact, for papers by Guglielmo Marco Migliorino Breakdown of academic impact, for papers by J. Timpone Breakdown of academic impact, for papers by Chiara Montrucchio Breakdown of academic impact, for papers by Alessia Zoncada Breakdown of academic impact, for papers by Andrés Esteban-Cantos Breakdown of academic impact, for papers by Carlos Azuaje Breakdown of academic impact, for papers by Bryan T. Mogle Breakdown of academic impact, for papers by Anjana Grandhi Breakdown of academic impact, for papers by Georgios Adamis
Rankless by CCL
2026